OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Clinical Immunology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee	387
The Ever-Increasing Array of Novel Inborn Errors of Immunity: an Interim Update by the IUIS Committee	161
The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity	161
Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses	108
Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study	95
Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain	91
Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency	91
SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage	86
Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy	82
Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis	65
SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best	64
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona	61
STAT3 Hyper-IgE Syndrome—an Update and Unanswered Questions	61
Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia	60
Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm	54
An Update on XMEN Disease	53
Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study	53
Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma	48
STING-Mediated Lung Inflammation and Beyond	47
Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency	47
Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency	45
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome	44
Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome	43
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome	41
Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations	41

Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients	40
A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19	39
COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico	38
IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2	38
Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2	37
COVID-19 in Patients with Primary Immunodeficiency	37
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β	37
Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital	36
Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers	35
Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy	34